Rocío Morón

1.2k total citations
25 papers, 976 citations indexed

About

Rocío Morón is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Rocío Morón has authored 25 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Oncology. Recurrent topics in Rocío Morón's work include Gut microbiota and health (6 papers), Clinical Nutrition and Gastroenterology (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Rocío Morón is often cited by papers focused on Gut microbiota and health (6 papers), Clinical Nutrition and Gastroenterology (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Rocío Morón collaborates with scholars based in Spain and United States. Rocío Morón's co-authors include Antonio Zarzuelo, Milagros Galisteo, Leonor Rivera, Manuel Sánchez, Júlio Gálvez, Maria Elena Rodríguez‐Cabezas, Per Anderson, Manuel Colmenero, J Cabeza Barrera and Alba Rodríguez‐Nogales and has published in prestigious journals such as Journal of Dairy Science, Biochemical Pharmacology and Nutrients.

In The Last Decade

Rocío Morón

20 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rocío Morón Spain 11 369 255 240 221 180 25 976
Saioa Gómez‐Zorita Spain 21 572 1.6× 384 1.5× 315 1.3× 413 1.9× 142 0.8× 50 1.4k
N. Arias Spain 16 571 1.5× 580 2.3× 260 1.1× 277 1.3× 146 0.8× 21 1.3k
Iñaki Milton‐Laskibar Spain 19 396 1.1× 282 1.1× 159 0.7× 287 1.3× 67 0.4× 43 985
Arrate Lasa Spain 23 534 1.4× 246 1.0× 283 1.2× 476 2.2× 161 0.9× 53 1.6k
Anuradha A. Shastri United States 6 247 0.7× 263 1.0× 83 0.3× 168 0.8× 214 1.2× 10 835
Kelly Korzeniewski United States 10 564 1.5× 476 1.9× 199 0.8× 458 2.1× 143 0.8× 12 1.6k
Priyanka Bapat United States 3 232 0.6× 212 0.8× 82 0.3× 167 0.8× 216 1.2× 6 755
In-Sook Kwun South Korea 8 260 0.7× 248 1.0× 82 0.3× 180 0.8× 232 1.3× 10 913
María José Zarzuelo-Romero Spain 17 438 1.2× 564 2.2× 102 0.4× 108 0.5× 314 1.7× 35 1.4k
Pema Raj Canada 16 171 0.5× 300 1.2× 212 0.9× 66 0.3× 110 0.6× 31 843

Countries citing papers authored by Rocío Morón

Since Specialization
Citations

This map shows the geographic impact of Rocío Morón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocío Morón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocío Morón more than expected).

Fields of papers citing papers by Rocío Morón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocío Morón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocío Morón. The network helps show where Rocío Morón may publish in the future.

Co-authorship network of co-authors of Rocío Morón

This figure shows the co-authorship network connecting the top 25 collaborators of Rocío Morón. A scholar is included among the top collaborators of Rocío Morón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocío Morón. Rocío Morón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Díaz-Villamarín, Xando, María Jesús Martínez-Pérez, Emilio Fernández-Varón, et al.. (2025). Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review. Pharmaceutics. 17(5). 542–542. 1 indexed citations
2.
Díaz-Villamarín, Xando, María Jesús Martínez-Pérez, Emilio Fernández-Varón, et al.. (2025). Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine. Journal of Personalized Medicine. 15(6). 245–245. 1 indexed citations
3.
4.
5.
Martínez-Pérez, María Jesús, Rocío Morón, Xando Díaz-Villamarín, et al.. (2024). Selective Digestive Decontamination: A Comprehensive Approach to Reducing Nosocomial Infections and Antimicrobial Resistance in the ICU. Journal of Clinical Medicine. 13(21). 6482–6482. 3 indexed citations
6.
7.
Colmenero, Manuel, et al.. (2024). Incidence of hypophosphataemia after ICU admission in mechanically ventilated patients and its relationship with risk factors for refeeding syndrome. Medicina Intensiva (English Edition). 48(6). 317–325. 2 indexed citations
8.
Diez‐Echave, Patricia, Natalia Chueca, Féderico García, et al.. (2023). Gut Microbiota Composition Can Predict Colonization by Multidrug-Resistant Bacteria in SARS-CoV-2 Patients in Intensive Care Unit: A Pilot Study. Antibiotics. 12(3). 498–498. 6 indexed citations
9.
Hidalgo‐Garcia, Laura, Antonio Jesús Ruiz‐Malagón, María Jesús Rodríguez‐Sojo, et al.. (2023). Administration of intestinal mesenchymal stromal cells reduces colitis-associated cancer in C57BL/6J mice modulating the immune response and gut dysbiosis. Pharmacological Research. 195. 106891–106891. 15 indexed citations
10.
Díaz-Villamarín, Xando, Emilio Fernández-Varón, José Luís Callejas-Rubio, et al.. (2023). Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation. Biomedicine & Pharmacotherapy. 168. 115706–115706. 10 indexed citations
11.
Díaz-Villamarín, Xando, et al.. (2022). Pharmacogenetics of siponimod: A systematic review. Biomedicine & Pharmacotherapy. 153. 113536–113536. 13 indexed citations
12.
Diez‐Echave, Patricia, Teresa Vezza, Francesca Algieri, et al.. (2022). The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome. Biomedicine & Pharmacotherapy. 153. 113445–113445. 12 indexed citations
13.
Vezza, Teresa, José Garrido‐Mesa, Patricia Diez‐Echave, et al.. (2021). Allium-Derived Compound Propyl Propane Thiosulfonate (PTSO) Attenuates Metabolic Alterations in Mice Fed a High-Fat Diet through Its Anti-Inflammatory and Prebiotic Properties. Nutrients. 13(8). 2595–2595. 18 indexed citations
14.
Morón, Rocío, et al.. (2020). Evaluation of quality indicators for nutrition and metabolism in critically ill patients: role of the pharmacist. European Journal of Hospital Pharmacy. 28(e1). e62–e65. 4 indexed citations
15.
Algieri, Francesca, José Garrido‐Mesa, Teresa Vezza, et al.. (2020). Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs. European Journal of Nutrition. 60(5). 2537–2551. 27 indexed citations
16.
Morón, Rocío, et al.. (2020). Evaluation of a Functional Restoration Program at Fort Bliss Interdisciplinary Pain Management Clinic. Military Medicine. 185(11-12). e2097–e2103. 7 indexed citations
17.
Morón, Rocío, Júlio Gálvez, Manuel Colmenero, et al.. (2019). The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition. Nutrients. 11(12). 3002–3002. 47 indexed citations
18.
19.
Rivera, Leonor, Rocío Morón, Antonio Zarzuelo, & Milagros Galisteo. (2008). Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochemical Pharmacology. 77(6). 1053–1063. 343 indexed citations
20.
Rivera, Leonor, Rocío Morón, Manuel Sánchez, Antonio Zarzuelo, & Milagros Galisteo. (2008). Quercetin Ameliorates Metabolic Syndrome and Improves the Inflammatory Status in Obese Zucker Rats. Obesity. 16(9). 2081–2087. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saioa Gómez‐Zorita Breakdown of academic impact, for papers by N. Arias Breakdown of academic impact, for papers by Iñaki Milton‐Laskibar Breakdown of academic impact, for papers by Arrate Lasa Breakdown of academic impact, for papers by Anuradha A. Shastri Breakdown of academic impact, for papers by Kelly Korzeniewski Breakdown of academic impact, for papers by Priyanka Bapat Breakdown of academic impact, for papers by In-Sook Kwun Breakdown of academic impact, for papers by María José Zarzuelo-Romero Breakdown of academic impact, for papers by Pema Raj
Rankless by CCL
2026